Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study Blood Cancer J
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype BRIT J HAEMATOL
Incidence, Risk Factors, and Impact of Early Cardiac Toxicity after Allogeneic Hematopoietic Cell Transplantation Blood Adv
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin Cell Rep
Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function (May, 10.1055/s-0043-1768510, 2023) KLIN PADIATR
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party BONE MARROW TRANSPL
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort Blood Cancer J
Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma Future Oncol
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia Cancer Cell Int
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Front Immunol